Hello and Welcome to Patientsville.com, Your Source for all VORICONAZOLE information. We are dedicated to provide You with VORICONAZOLE safety information. Learn about VORICONAZOLE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
VORICONAZOLE Safety Reports
Total VORICONAZOLE reports: 52.VORICONAZOLE FDA safety alerts: No.
Reported deaths: 11 Reported hospitalizations: 11.
Take VORICONAZOLE Side Effects Survey or Share Your VORICONAZOLE Story. Read More Here.
Physician from TURKEY reported VORICONAZOLE problem on Dec 21, 2006. Female patient, 16 years of age, weighting 176.4 lb, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, delirium, hallucination, mental impairment. VORICONAZOLE dosage: TEXT:3-4MG/KG. Patient recovered.
VORICONAZOLE problem was reported by a Health Professional from UNITED KINGDOM on Jan 08, 2007. Male patient, child 9 years of age, weighting 82.01 lb, was diagnosed with prophylaxis, transplant rejection and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, lymphoproliferative disorder, malaise, renal failure, sepsis. VORICONAZOLE dosage: unknown. During the same period patient was treated with TACROLIMUS, CALCIUM, OMEPRAZOLE, PREDNISOLONE, PROPRANOLOL. Patient died on 11/03/2006.
Physician from UNITED KINGDOM reported VORICONAZOLE problem on Jan 08, 2007. Male patient, child 12 years of age, weighting 103.3 lb, was diagnosed with bronchopulmonary aspergillosis allergic and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: blepharitis, ephelides, iritis, ocular hyperaemia, scleritis, sunburn. VORICONAZOLE dosage: unknown. Patient recovered.
VORICONAZOLE problem was reported by a Physician from UNITED KINGDOM on Jan 08, 2007. Female patient, child 10 years of age, weighting 83.78 lb, was diagnosed with bronchopulmonary aspergillosis, pseudomonas infection and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: ephelides, erythema. VORICONAZOLE dosage: unknown. During the same period patient was treated with CIPROFLOXACIN. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported VORICONAZOLE problem on Feb 02, 2007. Female patient, 32 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction, squamous cell carcinoma. VORICONAZOLE dosage: unknown. Patient recovered.
VORICONAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 15, 2007. Female patient, 55 years of age, was diagnosed with candidiasis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: pseudoporphyria. VORICONAZOLE dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, LIPITOR, FUROSEMIDE, CALCICHEW, AMLODIPINE, RISEDRONATE, BETALOC. Patient recovered.
Pharmacist from UNITED STATES reported VORICONAZOLE problem on Feb 28, 2007. Female patient, 34 years of age, was diagnosed with bronchopulmonary aspergillosis, renal transplant and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatitis acute, myositis. VORICONAZOLE dosage: 200MG PO QD. During the same period patient was treated with PROGRAF. Patient was hospitalized. Patient recovered.
VORICONAZOLE problem was reported by a Physician from SPAIN on Feb 20, 2007. Male patient, 35 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: bronchospasm. VORICONAZOLE dosage: unknown. Patient recovered.
Health Professional from UNITED KINGDOM reported VORICONAZOLE problem on Feb 27, 2007. Male patient, child 9 years of age, weighting 82.01 lb, was diagnosed with prophylaxis, fungal infection, transplant rejection and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, lymphoproliferative disorder, malaise, renal failure, sepsis. VORICONAZOLE dosage: unknown. During the same period patient was treated with TACROLIMUS, CALCIUM, OMEPRAZOLE, PREDNISOLONE, PROPRANOLOL. Patient died on 11/03/2006.
VORICONAZOLE problem was reported by a Health Professional from UNITED KINGDOM on Feb 22, 2007. Female patient, 49 years of age, weighting 240.3 lb, was diagnosed with aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, electromyogram abnormal, myalgia, tendon disorder. VORICONAZOLE dosage: unknown. During the same period patient was treated with AUGMENTIN, PREDNISOLONE, SERETIDE, VENTOLIN. Patient recovered.
Health Professional from UNITED STATES reported VORICONAZOLE problem on Feb 27, 2007. Female patient, 62 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, blood alkaline phosphatase increased, leukaemia recurrent, nausea, vomiting. VORICONAZOLE dosage: unknown. During the same period patient was treated with CANCIDAS, AMPHOTERICIN B. Patient died.
VORICONAZOLE problem was reported by a Pharmacist from UNITED STATES on Mar 19, 2007. Male patient, 52 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme abnormal, jaundice. VORICONAZOLE dosage: unknown. Patient recovered.
Physician from SPAIN reported VORICONAZOLE problem on Mar 09, 2007. Male patient, 83 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: palatal oedema. VORICONAZOLE dosage: DAILY DOSE:800MG. During the same period patient was treated with INSULIN, COZAAR, URBASON. Patient recovered.
VORICONAZOLE problem was reported by a Physician from EGYPT on Mar 14, 2007. Male patient, 47 years of age, was diagnosed with systemic candida, sarcoidosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: pneumonia fungal, sarcoidosis. VORICONAZOLE dosage: unknown. During the same period patient was treated with AZITHROMYCIN, ROCEPHIN. Patient died on 02/01/2007.
Physician from SPAIN reported VORICONAZOLE problem on Mar 15, 2007. Male patient, 77 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: delirium, diplopia, fluid retention, hallucination, hyponatraemia, vision blurred. VORICONAZOLE dosage: unknown. Patient was hospitalized. Patient recovered.
VORICONAZOLE problem was reported by a Pharmacist from UNITED STATES on Mar 27, 2007. Male patient, 81 years of age, was diagnosed with aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: agitation, amnesia, confusional state, disturbance in attention, dysarthria, encephalopathy, hallucination, nystagmus, pupillary reflex impaired. VORICONAZOLE dosage: 400 MG EVERY 12 HOURS IV. During the same period patient was treated with TYLENOL W, INHALERS, DILTIAZEM, COLACE, HALOPERIDOL, LORAZEPAM, ACTOS. Patient recovered.
Physician from SPAIN reported VORICONAZOLE problem on Mar 20, 2007. Male patient, 35 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: bronchospasm. VORICONAZOLE dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient recovered.
VORICONAZOLE problem was reported by a Physician from BRAZIL on Mar 28, 2007. Female patient was diagnosed with fungal sepsis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: leukocytosis, pathogen resistance, pyrexia, rash. VORICONAZOLE dosage: unknown. During the same period patient was treated with FLUCONAZOLE, MEROPENEM. Patient recovered.
Physician from SPAIN reported VORICONAZOLE problem on Mar 28, 2007. Male patient was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: palatal oedema. VORICONAZOLE dosage: DAILY DOSE:800MG. During the same period patient was treated with INSULIN, COZAAR, URBASON. Patient recovered.
VORICONAZOLE problem was reported by a Physician from AUSTRALIA on May 14, 2007. Female patient, 30 years of age, was treated with VORICONAZOLE. VORICONAZOLE dosage: unknown. During the same period patient was treated with ITRACONAZOLE, AMPHOTERICIN B. Patient died.
Physician from PORTUGAL reported VORICONAZOLE problem on May 16, 2007. Female patient, weighting 138.9 lb, was diagnosed with neutropenia and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood lactate dehydrogenase increased, catheter related complication, myelofibrosis, neutropenia, oral candidiasis, pancytopenia, thrombocytopenia, tracheobronchitis. VORICONAZOLE dosage: unknown. During the same period patient was treated with NEUPOGEN, ADALAT, DIOSMIN, ACARBOSE, IDARUBICIN, CYTARABINE, MITOXANTRONE. Patient was hospitalized. Patient recovered.
VORICONAZOLE problem was reported by a Physician from TUNISIA on May 17, 2007. Female patient, 35 years of age, was diagnosed with aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: dry mouth, dry skin, lip dry, melanodermia, photosensitivity reaction. VORICONAZOLE dosage: DAILY DOSE:200MG. During the same period patient was treated with AZATHIOPRINE, PREDNISONE. Patient recovered.
Physician from AUSTRALIA reported VORICONAZOLE problem on Apr 27, 2007. Female patient, 30 years of age, was treated with VORICONAZOLE. VORICONAZOLE dosage: unknown. During the same period patient was treated with ITRACONAZOLE, AMPHOTERICIN B. Patient died.
VORICONAZOLE problem was reported by a Consumer or non-health professional from FRANCE on May 25, 2007. Female patient, weighting 101.4 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: anorexia, arthralgia. VORICONAZOLE dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, ACAMPROSATE, VALIUM, TARDYFERON, ATHYMIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VORICONAZOLE problem on June 11, 2007. Male patient, 62 years of age, weighting 167.6 lb, was diagnosed with fungal infection, hypercholesterolaemia and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, liver function test abnormal. VORICONAZOLE dosage: unknown. During the same period patient was treated with VYTORIN. Patient recovered.
VORICONAZOLE problem was reported by a Physician from UNITED KINGDOM on June 14, 2007. Male patient, 62 years of age, weighting 174.2 lb, was diagnosed with antifungal prophylaxis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: bundle branch block right, heart rate irregular. VORICONAZOLE dosage: DAILY DOSE:200MG. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, OMEPRAZOLE, PENICILLIN. Patient recovered.
Pharmacist from ITALY reported VORICONAZOLE problem on July 05, 2006. Male patient, 39 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: haematuria, photophobia, pseudomonas infection, toxic epidermal necrolysis. VORICONAZOLE dosage: 6 MG/KG, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
VORICONAZOLE problem was reported by a Physician from UNITED KINGDOM on July 19, 2006. Female patient, 60 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: blister, ulcer. VORICONAZOLE dosage: unknown. Patient recovered.
Physician from UNITED KINGDOM reported VORICONAZOLE problem on Aug 11, 2006. Female patient, 55 years of age, was diagnosed with candidiasis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: porphyria, pseudoporphyria, skin ulcer. VORICONAZOLE dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, LIPITOR, FUROSEMIDE, CALCICHEW, AMLODIPINE, RISEDRONATE, BETALOC. Patient recovered.
VORICONAZOLE problem was reported by a Pharmacist from UNITED STATES on Aug 28, 2006. Male patient was diagnosed with fungaemia, myocardial infarction, sepsis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, hepatic failure, jaundice. VORICONAZOLE dosage: unknown. During the same period patient was treated with PLAVIX, ZOSYN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported VORICONAZOLE problem on Sept 06, 2006. Male patient, 68 years of age, weighting 165.3 lb, was diagnosed with aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: burning sensation, hypoaesthesia. VORICONAZOLE dosage: 450 MG (150 MG, 3 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, AZITHROMYCIN, LISINOPRIL, PRAVASTATIN. Patient recovered.
VORICONAZOLE problem was reported by a Pharmacist from UNITED STATES on Sept 27, 2006. Male patient, 76 years of age, weighting 141.0 lb, was diagnosed with aspergillosis, rheumatoid arthritis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: blister, blood creatinine increased, bloody discharge, open wound, photosensitivity reaction, platelet count decreased. VORICONAZOLE dosage: 200MG BID PO. During the same period patient was treated with METHOTREXATE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VORICONAZOLE problem on Sept 19, 2006. Male patient, 70 years of age, weighting 149.3 lb, was diagnosed with acute myeloid leukaemia and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, catheter related complication, hepatotoxicity, hypernatraemia, hypokalaemia, induration, renal impairment. VORICONAZOLE dosage: unknown. During the same period patient was treated with NORFLOXACIN, VALACYCLOVIR, GATIFLOXACIN, ALLOPURINOL, ATENOLOL, LEVAQUIN, PREDNISONE. Patient was hospitalized. Patient recovered.
VORICONAZOLE problem was reported by a Physician from THAILAND on Sept 26, 2006. Female patient, 28 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, blood creatinine increased, hyperbilirubinaemia, liver function test abnormal. VORICONAZOLE dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with IMIPENEM. Patient was hospitalized. Patient died on 07/12/2006.
Physician from NETHERLANDS reported VORICONAZOLE problem on Sept 28, 2006. Male patient, 53 years of age, was diagnosed with fungal infection and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: arthralgia, cryptogenic organising pneumonia, graft versus host disease, hepatic enzyme increased, pulmonary toxicity. VORICONAZOLE dosage: unknown. During the same period patient was treated with POSACONAZOLE, AMPHOTERICIN B, ITRACONAZOLE. Patient recovered.
VORICONAZOLE problem was reported by a Health Professional from UNITED KINGDOM on Oct 03, 2006. Female patient, 55 years of age, weighting 143.3 lb, was diagnosed with candidiasis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: blister, pseudoporphyria. VORICONAZOLE dosage: 200 MG, 2 IN 1 D, ORAL. During the same period patient was treated with FUROSEMIDE. Patient recovered.
Pharmacist from UNITED STATES reported VORICONAZOLE problem on Oct 26, 2006. Male patient, 76 years of age, weighting 141.0 lb, was diagnosed with aspergillosis, rheumatoid arthritis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: blister, blood creatinine increased, bloody discharge, open wound, photosensitivity reaction, platelet count decreased. VORICONAZOLE dosage: 200 MG BID ORAL. During the same period patient was treated with METHOTREXATE. Patient recovered.
VORICONAZOLE problem was reported by a Physician from TURKEY on Oct 16, 2006. Male patient, 25 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: epistaxis, gingival bleeding, haemoptysis. VORICONAZOLE dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE. Patient recovered.
Health Professional from UNITED KINGDOM reported VORICONAZOLE problem on Nov 13, 2006. Male patient, 26 years of age, was diagnosed with bronchopulmonary aspergillosis allergic and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: body temperature increased, c-reactive protein increased, photosensitivity reaction. VORICONAZOLE dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AZITHROMYCIN, CALCICHEW, CREON, PULMOZYME, FLUTICASONE PROPIONATE, OMEPRAZOLE, TAURINE, URSODIOL. Patient was hospitalized. Patient recovered.
VORICONAZOLE problem was reported by a Physician from THAILAND on Nov 21, 2006. Female patient, 28 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, blood creatinine increased, hyperbilirubinaemia, liver function test abnormal. VORICONAZOLE dosage: 600 MG (300 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with IMIPENEM. Patient was hospitalized. Patient died on 07/12/2006.
Physician from TURKEY reported VORICONAZOLE problem on Nov 20, 2006. Female patient was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: facial palsy. VORICONAZOLE dosage: unknown. During the same period patient was treated with CASPOGUNGIN. Patient recovered.
VORICONAZOLE problem was reported by a Consumer or non-health professional from on June 21, 2007. Female patient, 46 years of age, was diagnosed with scedosporium infection and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: scedosporium infection. VORICONAZOLE dosage: unknown. Patient died.
Consumer or non-health professional from UNITED STATES reported VORICONAZOLE problem on July 20, 2007. Female patient, 62 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: paranoia. VORICONAZOLE dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient recovered.
VORICONAZOLE problem was reported by a Consumer or non-health professional from JAPAN on July 11, 2007. Male patient, 59 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: mucormycosis. VORICONAZOLE dosage: unknown. During the same period patient was treated with MICAFUNGIN, AMPHOTERICIN B. Patient died.
Consumer or non-health professional from UNITED STATES reported VORICONAZOLE problem on July 16, 2007. Male patient, 54 years of age, was diagnosed with antifungal prophylaxis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, multi-organ failure, pleural effusion, respiratory failure, venoocclusive liver disease, zygomycosis. VORICONAZOLE dosage: unknown. During the same period patient was treated with THALIDOMIDE, CASPOFUNGIN. Patient recovered.
VORICONAZOLE problem was reported by a Consumer or non-health professional from SWITZERLAND on July 17, 2007. Male patient, 53 years of age, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, febrile neutropenia, staphylococcal infection. VORICONAZOLE dosage: unknown. During the same period patient was treated with CEFEPIME, IMIPENEM, LEVOFLOXACIN, TEICOPLANIN, FLUCONAZOLE, METRONIDAZOLE. Patient recovered.
Physician from FRANCE reported VORICONAZOLE problem on Aug 01, 2007. Female patient, weighting 123.5 lb, was diagnosed with aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: ageusia, hallucination, paraesthesia, unevaluable event, visual disturbance. VORICONAZOLE dosage: unknown. Patient recovered.
VORICONAZOLE problem was reported by a Physician from FRANCE on Aug 14, 2007. Male patient, weighting 163.1 lb, was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: photosensitivity reaction. VORICONAZOLE dosage: unknown. During the same period patient was treated with PROGRAF, AZATHIOPRINE, CORTANCYL, ZITHROMAX, NEXIUM, PREVISCAN, NOVONORM. Patient recovered.
Consumer or non-health professional from JAPAN reported VORICONAZOLE problem on Aug 24, 2007. Male patient, 59 years of age, weighting 125.7 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: mucormycosis. VORICONAZOLE dosage: DAILY DOSE:400MG. During the same period patient was treated with MICAFUNGIN, AMPHOTERICIN B. Patient died.
VORICONAZOLE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 30, 2007. Female patient, weighting 104.7 lb, was diagnosed with prophylaxis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: eye swelling, mucormycosis, myalgia, productive cough. VORICONAZOLE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, ACYCLOVIR, CIPROFLOXACIN, OMEPRAZOLE, PARACETAMOL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported VORICONAZOLE problem on Sept 21, 2007. Male patient, 59 years of age, weighting 189.6 lb, was diagnosed with fungal infection and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, fall, hallucinations, mixed, screaming. VORICONAZOLE dosage: 200MG BID PO. During the same period patient was treated with ACYCLOVIR, CIPROFLOXACIN, PIPERACILLIN AND TAZOBACTAM, NEUPOGEN, INSULIN GLARGINE, REGULAR INSULIN, ADVAIR DISKUS, TESSALON PEARLES. Patient recovered.
VORICONAZOLE problem was reported by a Consumer or non-health professional from AUSTRIA on Sept 18, 2007. Male patient, 45 years of age, weighting 220.5 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: hyperventilation, loss of consciousness. VORICONAZOLE dosage: DAILY DOSE:2MG/KG. Patient recovered.